Bert has prepared and prosecuted U.S. and international patent applications in various sectors and technologies, including:  

• Represented a large company in advancing patent protections around the world for advancement and clinical testing of the first vaccine against a rapidly spreading viral infection known to infect livestock and humans
• Negotiated several complex life science technology-related agreements for start-up companies 
• Biotechnology, including vaccines development against infectious diseases (e.g. bacterial, fungal and viral), neglected diseases (e.g. flaviviruses and alphaviruses) and cancer
• Formulations for manufacturing and delivery of pharmaceutical agents
• Immunology-related technologies
• Treatment and prevention of inflammatory-related conditions
• Transplantation (e.g. organ, soft tissue and cellular) and GvHD
• Pharmaceuticals (e.g. chemical, small molecule and biologics) and modes of administration
• Secondary use of biological and pharmaceuticals
• Oncology and genetic disorders
• Recombinant technologies, gene editing and CRISPR technologies
• Biofuels, including alternative fuels production in microorganisms
• Agriculture, including transgenic plants and growth stimulants/additives
• Veterinary medicines/vaccines/treatments (e.g. large and small animals)
• Health supplements, nutrition substitutes and herbal medicines